Edwina Parrish Littlejohn, PA
Surgical · Kansas City, MONPI 1235101528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,036 and has fallen 50.9% since, to $509 in 2025.
Across 74 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$347
- AbbVie$163
- Teva Pharmaceuticals USA, Inc.$160
- UCB, Inc.$149
- Nevro Corp.$135
- 180 Medical, Inc.$118
- plus $645 from 16 others
What the payments were for
- Food & beverage$1,718100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 9 | $347 |
| AbbVie | 11 | $163 |
| Teva Pharmaceuticals USA, Inc. | 10 | $160 |
| UCB, Inc. | 7 | $149 |
| Nevro Corp. | 1 | $135 |
| 180 Medical, Inc. | 6 | $118 |
| Acadia Pharmaceuticals Inc | 6 | $113 |
| Kyowa Kirin, Inc. | 4 | $83 |
| Grifols USA, LLC | 2 | $63 |
| Genentech USA, Inc. | 2 | $55 |
| Alnylam Pharmaceuticals Inc. | 3 | $50 |
| Biogen | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Neurelis, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| SK Life Science, Inc. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Argenx US, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,718 in reported general payments places this provider in the 85th percentile of 118 surgical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical in Kansas City
- Mackenzie SnyderKansas City$2K
- Patrick EggerKansas City$1K
- Meredith AnninKansas City$1K
- Kari SemmesKansas City$728
- Alyson ClarkKansas City$562
- Hannah EagleburgerKansas City$553
- Rachel ManskeKansas City$530
- Morgan WalkerKansas City$513
- Paul JenkinsKansas City$349
- Ciara GlennSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.